knowledge -WSS

knowledge

author：fashion 2025-09-29 16:34:26 - browse：25718

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： The Bio Revolution is changing business and society

Wikipedia

WSS

The Bio Revolution is changing business and society

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Hospitals need to get ahead of regulations on climate change

The Bio Revolution is changing business and society

Stroke rates rising, especially in working

Hospitals need to get ahead of regulations on climate change

entertainment

knowledge

leisure time

Medicare details structure of new drug price negotiation program

Lawsuit challenges CMS nursing home minimum staffing rule

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Achieving telehealth equity for people with hearing loss

Hepatitis C has a cure — but many Americans still lack access to it

Lawsuit challenges CMS nursing home minimum staffing rule

Hollywood unions extend contract negotiations for actors

Why we need mandatory labeling of GMO products

Cancer drug shortages should be causing more outrage

Clinicians often fail to acknowledge the pain caused by long Covid

leisure time

Achieving telehealth equity for people with hearing loss

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Guardant Health colon cancer test endorsed by FDA advisory panel

Decentralized clinical trials need collaboration to achieve wider use

Unmasking the 'centricity' illusion in clinical trials

Protect nursing home residents from future pandemics

Wikipedia

explore

entertainment

explore